DAX
18.163,52 -90,66 (-0,50%) Euro Stoxx 50
4.907,30 -40,43 (-0,82%) Dow Jones 30
39.150,33 +15,57 (+0,04%) Gold
2.334,70 -34,30 (-1,45%) EUR/USD
1,0697 -0,0009 (-0,09%) Bitcoin EUR
60.247,45 +127,34 (+0,21%)
Medpace Holdings, Inc. (01P.F)
Medpace Holdings, Inc.
5375 Medpace Way
Cincinnati, OH 45227
United States
513 579 9911
https://www.medpace.com
Sektor(en): Healthcare
Branche: Diagnostics & Research
Vollzeitmitarbeiter: 5.800
Beschreibung
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Corporate Governance
Medpace Holdings, Inc.s ISS Governance QualityScore, Stand 1. Juni 2024, lautet 7. Die grundlegenden Scores sind Audit: 5, Vorstand: 9, Shareholderrechte: 7, Kompensation: 4.
